NCT02712788

Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage

• Status: Terminated
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 4 (actual)
• Sponsor: Indiana University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the usefulness of adding Milrinone to the current standard treatment for cerebral vasospasm.

Detailed description

The goal of this study is to assess the efficacy of milrinone as an agent to treat cerebral vasospasm by adding it to standard therapy. This will take the form of a randomized, controlled trial in which patients will receive either standard hyperdynamic therapy or hyperdynamic therapy + milrinone. The hypothesis of this study is that good outcomes will be 25% more common in the experimental (milrinone) group than the control (standard therapy) group.

Conditions

• Cerebral Vasospasm

Interventions

Type	Name	Description
DRUG	Milrinone
DRUG	Placebo

Timeline

• Start date: 2016-04-18
• Primary completion: 2017-10-24
• Completion: 2018-05-03
• First posted: 2016-03-18
• Last updated: 2019-07-02
• Results posted: 2019-07-02

Locations

1 site across 1 country: United States